These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21316533)

  • 21. Individualisation of antiviral therapy for chronic hepatitis C.
    Teoh NC; Farrell GC; Chan HL
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1206-16. PubMed ID: 20594246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNA.
    Shiratori Y; Yokosuka O; Nakata R; Ihori M; Hirota K; Katamoto T; Unuma T; Okano K; Ikeda Y; Hirano M; Kawase T; Takano S; Matsumoto K; Ohashi Y; Omata M
    Hepatology; 1999 May; 29(5):1573-80. PubMed ID: 10216145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatitis C in drug addicts: access and treatment compliance].
    Sarmento E Castro R; Valente C; Ramos JP; Almeida JR; Marinho RT; Branco T; Andrade S; Macedo A
    Acta Med Port; 2011 Dec; 24 Suppl 2():483-92. PubMed ID: 22849938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C treatment candidacy and outcomes among 4318 US veterans with chronic hepatitis C virus infection: does a history of injection drug use matter?
    Seal KH; Currie SL; Shen H; Anand BS; Bini EJ; Brau N; Jeffers L; Wright TL;
    J Clin Gastroenterol; 2007 Feb; 41(2):199-205. PubMed ID: 17245220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Management of hepatitis C among drug user patients].
    Moussalli J; Melin P; Wartelle-Bladou C; Lang JP
    Gastroenterol Clin Biol; 2007; 31(8-9 Pt 3):4S51-5. PubMed ID: 17965636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of depression in former injection drug users with chronic hepatitis C.
    Scott JD; Wang CC; Coppel E; Lau A; Veitengruber J; Roy-Byrne P
    J Clin Gastroenterol; 2011; 45(5):462-7. PubMed ID: 21293293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Predictors of adherence to treatment of chronic hepatitis C in drug-dependent inmate patients in four prisons in Barcelona, Spain].
    Marco Mouriño A; da Silva Morán A; Ortiz Seuma J; Solé Carbó C; Roget Alemany M; Sarriera Gracia C; Teixidó Pérez N; Robres Guillén P; Guerrero Moreno RA
    Rev Esp Salud Publica; 2010; 84(4):423-31. PubMed ID: 21141269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis C.
    Rowan PJ; Tabasi S; Abdul-Latif M; Kunik ME; El-Serag HB
    J Clin Gastroenterol; 2004 Jul; 38(6):530-4. PubMed ID: 15220690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of stimulant use on antiviral treatment in an integrated hepatitis clinic.
    Dieperink E; Knott A; Thuras P; Pocha C
    Gen Hosp Psychiatry; 2013; 35(4):387-92. PubMed ID: 23391612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of treatment with direct-acting antiviral (DAA) in clinical practice.
    Fontanges T
    Clin Res Hepatol Gastroenterol; 2011 Dec; 35 Suppl 2():S64-8. PubMed ID: 22248697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Difficulties with interferon treatment in former intravenous drug users.
    Gazdag G; Horváth G; Szabó O; Ungvari GS
    Braz J Infect Dis; 2011; 15(2):163-6. PubMed ID: 21503405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2.
    Gane E; Kershenobich D; Seguin-Devaux C; Kristian P; Aho I; Dalgard O; Shestakova I; Nymadawa P; Blach S; Acharya S; Anand AC; Andersson MI; Arendt V; Arkkila P; Baatarkhuu O; Barclay K; Ben-Ari Z; Bergin C; Bessone F; Blokhina N; Brunton CR; Choudhuri G; Chulanov V; Cisneros L; Croes EA; Dahgwahdorj YA; Daruich JR; Dashdorj NR; Davaadorj D; de Knegt RJ; de Vree M; Gadano AC; Gower E; Halota W; Hatzakis A; Henderson C; Hoffmann P; Hornell J; Houlihan D; Hrusovsky S; Jarčuška P; Kostrzewska K; Leshno M; Lurie Y; Mahomed A; Mamonova N; Mendez-Sanchez N; Mossong J; Norris S; Nurmukhametova E; Oltman M; Oyunbileg J; Oyunsuren Ts; Papatheodoridis G; Pimenov N; Prins M; Puri P; Radke S; Rakhmanova A; Razavi H; Razavi-Shearer K; Reesink HW; Ridruejo E; Safadi R; Sagalova O; Sanchez Avila JF; Sanduijav R; Saraswat V; Schréter I; Shah SR; Shevaldin A; Shibolet O; Silva MO; Sokolov S; Sonderup M; Souliotis K; Spearman CW; Staub T; Stedman C; Strebkova EA; Struck D; Sypsa V; Tomasiewicz K; Undram L; van der Meer AJ; van Santen D; Veldhuijzen I; Villamil FG; Willemse S; Zuckerman E; Zuure FR; Prabdial-Sing N; Flisiak R; Estes C
    J Viral Hepat; 2015 Jan; 22 Suppl 1():46-73. PubMed ID: 25560841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C Virus Treatment and Injection Drug Users: It Is Time to Separate Fact From Fiction.
    McCance-Katz EF; Valdiserri RO
    Ann Intern Med; 2015 Aug; 163(3):224-5. PubMed ID: 26120801
    [No Abstract]   [Full Text] [Related]  

  • 34. Tuberculous sepsis during antiviral HCV triple therapy.
    Hametner S; Monticelli F; Kern JM; Schöfl R; Ziachehabi A; Maieron A
    J Hepatol; 2013 Sep; 59(3):637-8. PubMed ID: 23669285
    [No Abstract]   [Full Text] [Related]  

  • 35. Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS.
    Ford N; Singh K; Cooke GS; Mills EJ; von Schoen-Angerer T; Kamarulzaman A; du Cros P
    Clin Infect Dis; 2012 May; 54(10):1465-72. PubMed ID: 22431808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute?
    Evon DM; Golin CE; Fried MW; Keefe FJ
    J Consult Clin Psychol; 2013 Apr; 81(2):361-74. PubMed ID: 22730952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?
    Edlin BR; Seal KH; Lorvick J; Kral AH; Ciccarone DH; Moore LD; Lo B
    N Engl J Med; 2001 Jul; 345(3):211-5. PubMed ID: 11463019
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis C treatment in drug users: perception versus evidence.
    Sylvestre D
    Eur J Gastroenterol Hepatol; 2006 Feb; 18(2):129-30. PubMed ID: 16394792
    [No Abstract]   [Full Text] [Related]  

  • 39. [Achieve a higher cure rate via standardized antiviral therapy for chronic hepatitis C].
    Xie Y; Li MH
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):408-9. PubMed ID: 24490301
    [No Abstract]   [Full Text] [Related]  

  • 40. Optimal HCV combination therapy?].
    Prescrire Int; 2015 Dec; 24(166):288. PubMed ID: 26788570
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.